Juni 2018 - Seite 2 von 2 - IOZK

Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial.

2018-06-03/in Dendritic Cells, NSCLC /von 2018-06-03 / J Clin Oncol 36, 2018 (suppl; abstr 9051)

The effect of Newcastle disease virus on tumor proliferation and cellular immunity.

2018-06-01/in International Publications, Newcastle Disease Virus /von 2018-06-01 / J Clin Oncol 36, 2018 (suppl; abstr e15174)

Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with recurrent epithelial ovarian carcinoma (EOC) after complete response (CR) to 1st-line platinum (Pt)-based ct: Primary analysis of a phase 2, open-label, randomized, multicenter trial.

2018-06-01/in Dendritic Cells, International Publications, Ovarian Cancer /von 2018-06-01 / J Clin Oncol 36, 2018 (suppl; abstr e17515)

The Efficacy of Radiofrequency Hyperthermia Combined with Chemotherapy in the Treatment of Advanced Ovarian Cancer

2018-06-01/in Hyperthermia, International Publications, Ovarian Cancer /von 2018-06-01 / Open Med (Wars) 2018;13:83-89